Questions regarding the optimal use of bevacizumab in glioblastoma: A moving target

Roger Stupp; Michael Weller

doi:10.1093/neuonc/nou092

Questions regarding the optimal use of bevacizumab in glioblastoma: A moving target

Roger Stupp^*, Michael Weller

^*Corresponding author for this work

Neurological Surgery

Research output: Contribution to journal › Editorial › peer-review

14 Scopus citations

Original language	English (US)
Pages (from-to)	765-767
Number of pages	3
Journal	Neuro-oncology
Volume	16
Issue number	6
DOIs	https://doi.org/10.1093/neuonc/nou092
State	Published - Jun 2014

ASJC Scopus subject areas

Clinical Neurology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/neuonc/nou092

Cite this

@article{41b48ee917bb43909c46cbb9ad0e83c5,

title = "Questions regarding the optimal use of bevacizumab in glioblastoma: A moving target",

author = "Roger Stupp and Michael Weller",

year = "2014",

month = jun,

doi = "10.1093/neuonc/nou092",

language = "English (US)",

volume = "16",

pages = "765--767",

journal = "Neuro-oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Questions regarding the optimal use of bevacizumab in glioblastoma

T2 - A moving target

AU - Stupp, Roger

AU - Weller, Michael

PY - 2014/6

Y1 - 2014/6

UR - http://www.scopus.com/inward/record.url?scp=84901060435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901060435&partnerID=8YFLogxK

U2 - 10.1093/neuonc/nou092

DO - 10.1093/neuonc/nou092

M3 - Editorial

C2 - 24826844

AN - SCOPUS:84901060435

SN - 1522-8517

VL - 16

SP - 765

EP - 767

JO - Neuro-oncology

JF - Neuro-oncology

IS - 6

ER -

Questions regarding the optimal use of bevacizumab in glioblastoma: A moving target

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this